ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 300 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,197,150 | +8149.4% | 217,000 | +14366.7% | 1.24% | +7211.8% |
| Q1 2020 | $63,000 | -99.3% | 1,500 | -99.3% | 0.02% | -99.0% |
| Q4 2019 | $8,834,000 | +22.7% | 206,500 | +3.2% | 1.73% | -33.4% |
| Q3 2019 | $7,198,000 | +34.6% | 200,000 | 0.0% | 2.60% | +59.8% |
| Q2 2019 | $5,346,000 | -0.4% | 200,000 | 0.0% | 1.63% | +9.5% |
| Q1 2019 | $5,370,000 | +70.3% | 200,000 | +2.6% | 1.49% | +26.3% |
| Q4 2018 | $3,153,000 | -22.1% | 195,000 | 0.0% | 1.18% | +14.3% |
| Q3 2018 | $4,048,000 | – | 195,000 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |